Stock & Company Details
Curis Inc $CRIS
Price:
N/A
N/A
2.1M
$3.6M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.14
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CRIS technical indicators
Latest Curis Inc (CRIS) indicator readings as of 2026-08-28.
CRIS's 14-day RSI is 27.4, in oversold territory. At $1.49 it is trading 6.7% above its 200-day moving average of $1.40, and below its 50-day average of $3.04. Price sits in the middle of its Bollinger Bands ($-0.06 to $5.08). ADX reads 36.0, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Finance Bot
Ask your questions
Start by typing a question below.
